Jaktinib,hydroxyurea
suzhou zelgen
['mpnsm', '#mpn', '#myelof', 'hydroxyurea']
#jaktinib led to a statistically significant improvement in the proportion of patients with a spleen-volume reduction of at least 35% from baseline at week 24 vs hydroxyurea in patients with intermediate-2 or high-risk #myelofibrosis. #mpnsm #eha2023 
Oncology news and insights from leading researchers and cancer centers.